311 related articles for article (PubMed ID: 19895368)
1. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.
Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C
Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162
[TBL] [Abstract][Full Text] [Related]
3. Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis.
Wang KH; Kao AP; Chang CC; Lee JN; Hou MF; Long CY; Chen HS; Tsai EM
Mol Cancer; 2010 Nov; 9():288. PubMed ID: 21044318
[TBL] [Abstract][Full Text] [Related]
4. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
[TBL] [Abstract][Full Text] [Related]
5. Promotion of epithelial-mesenchymal transition and tumor growth by 17β-estradiol in an ER(+)/HER2(+) cell line derived from human breast epithelial stem cells.
Wang KH; Kao AP; Lin TC; Chang CC; Kuo TC
Biotechnol Appl Biochem; 2012; 59(3):262-7. PubMed ID: 23586837
[TBL] [Abstract][Full Text] [Related]
6. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
7. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
Mosoyan G; Nagi C; Marukian S; Teixeira A; Simonian A; Resnick-Silverman L; DiFeo A; Johnston D; Reynolds SR; Roses DF; Mosoian A
PLoS One; 2013; 8(1):e55145. PubMed ID: 23372829
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
Oon ML; Thike AA; Tan SY; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):31-41. PubMed ID: 25677743
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
[TBL] [Abstract][Full Text] [Related]
11. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach.
Turner C; Kohandel M
J Theor Biol; 2010 Aug; 265(3):329-35. PubMed ID: 20648969
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
13. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
14. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
[TBL] [Abstract][Full Text] [Related]
15. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
16. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
[TBL] [Abstract][Full Text] [Related]
17. ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells.
Deng H; Yin L; Zhang XT; Liu LJ; Wang ML; Wang ZY
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():417-26. PubMed ID: 25158023
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
19. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Weitzenfeld P; Meshel T; Ben-Baruch A
Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
[TBL] [Abstract][Full Text] [Related]
20. PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells.
Vidal LJ; Perry JK; Vouyovitch CM; Pandey V; Brunet-Dunand SE; Mertani HC; Liu DX; Lobie PE
Mol Cancer Res; 2010 Mar; 8(3):444-56. PubMed ID: 20197384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
